Header Logo

Connection

REVATHY B IYER to Adult

Back to Details
This is a "connection" page, showing publications REVATHY B IYER has written about Adult.
REVATHY B IYER
Connection Strength
0.272
Adult
  1. Increase in post-therapy tumor calcification on CT scan is not an indicator of response to therapy in low-grade serous ovarian cancer. Abdom Radiol (NY). 2016 08; 41(8):1589-95.
    View in: PubMed
    Score: 0.021
  2. Diaphragmatic hernia after esophagectomy for esophageal malignancy. J Thorac Imaging. 2013 Sep; 28(5):308-14.
    View in: PubMed
    Score: 0.017
  3. MRI is highly specific in determining primary cervical versus endometrial cancer when biopsy results are inconclusive. Clin Radiol. 2013 Nov; 68(11):1107-13.
    View in: PubMed
    Score: 0.017
  4. Multidetector computed tomography follow-up of hypoattenuating small liver lesions in patients with rectal cancer. Am J Clin Oncol. 2011 Aug; 34(4):411-6.
    View in: PubMed
    Score: 0.015
  5. Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels. Int J Gynecol Cancer. 2010 Aug; 20(6):936-44.
    View in: PubMed
    Score: 0.014
  6. Magnetic resonance imaging of endometrial carcinoma. J Comput Assist Tomogr. 2009 Jul-Aug; 33(4):601-8.
    View in: PubMed
    Score: 0.013
  7. PET/CT and hepatic radiation injury in esophageal cancer patients. Cancer Imaging. 2007 Nov 26; 7:189-94.
    View in: PubMed
    Score: 0.012
  8. Imaging in the diagnosis, staging, and follow-up of colorectal cancer. AJR Am J Roentgenol. 2002 Jul; 179(1):3-13.
    View in: PubMed
    Score: 0.008
  9. Longitudinal Changes in Bone Mineral Measurements Inside and Outside Radiation Fields Used for Cervical Cancer Treatment. Pract Radiat Oncol. 2022 Sep-Oct; 12(5):e423-e433.
    View in: PubMed
    Score: 0.008
  10. Imaging findings after radiotherapy to the pelvis. AJR Am J Roentgenol. 2001 Nov; 177(5):1083-9.
    View in: PubMed
    Score: 0.008
  11. The role of neoadjuvant chemotherapy in the management of low-grade serous carcinoma of the ovary and peritoneum: Further evidence of relative chemoresistance. Gynecol Oncol. 2020 09; 158(3):653-658.
    View in: PubMed
    Score: 0.007
  12. Pelvic fractures and changes in bone mineral density after radiotherapy for cervical, endometrial, and vaginal cancer: A prospective study of 239 women. Cancer. 2020 06 01; 126(11):2607-2613.
    View in: PubMed
    Score: 0.007
  13. Esophageal pneumatosis: Case report and review of literature. Clin Imaging. 2019 Nov - Dec; 58:15-21.
    View in: PubMed
    Score: 0.006
  14. Characteristics and outcomes of patients with recurrent ovarian cancer undergoing early phase immune checkpoint inhibitor clinical trials. Gynecol Oncol. 2018 12; 151(3):407-413.
    View in: PubMed
    Score: 0.006
  15. Can MRI help assess aggressiveness of endometrial cancer? Clin Radiol. 2018 09; 73(9):833.e11-833.e18.
    View in: PubMed
    Score: 0.006
  16. Late sequelae after radiation therapy for breast cancer: imaging findings. AJR Am J Roentgenol. 1997 May; 168(5):1335-8.
    View in: PubMed
    Score: 0.006
  17. A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancer. Gynecol Oncol. 2017 Apr; 145(1):27-31.
    View in: PubMed
    Score: 0.005
  18. Potential Application of Dual-Energy CT in Gynecologic Cancer: Initial Experience. AJR Am J Roentgenol. 2017 Mar; 208(3):695-705.
    View in: PubMed
    Score: 0.005
  19. Can reduced field-of-view diffusion sequence help assess microsatellite instability in FIGO stage 1 endometrial cancer? J Magn Reson Imaging. 2017 04; 45(4):1216-1224.
    View in: PubMed
    Score: 0.005
  20. Is MRI helpful in assessing the distance of the tumour from the internal os in patients with cervical cancer below FIGO Stage IB2? Clin Radiol. 2016 Jun; 71(6):515-22.
    View in: PubMed
    Score: 0.005
  21. Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer. J Magn Reson Imaging. 2016 Feb; 43(2):316-24.
    View in: PubMed
    Score: 0.005
  22. Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: time to reconsider the FIGO staging system? Gynecol Oncol. 2015 Feb; 136(2):269-73.
    View in: PubMed
    Score: 0.005
  23. A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer. Gynecol Oncol. 2014 Sep; 134(3):455-61.
    View in: PubMed
    Score: 0.005
  24. Diaphragmatic hernia after esophagectomy in 440 patients with long-term follow-up. Ann Thorac Surg. 2013 Oct; 96(4):1138-1145.
    View in: PubMed
    Score: 0.004
  25. Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):1045-50.
    View in: PubMed
    Score: 0.004
  26. Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum. Gynecol Oncol. 2012 Jun; 125(3):661-6.
    View in: PubMed
    Score: 0.004
  27. The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. Int J Gynecol Cancer. 2012 Jan; 22(1):123-31.
    View in: PubMed
    Score: 0.004
  28. Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer. Lancet Oncol. 2011 Nov; 12(12):1109-17.
    View in: PubMed
    Score: 0.004
  29. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of Radiation Therapy Oncology Group (RTOG) 0116. Int J Gynecol Cancer. 2011 Oct; 21(7):1266-75.
    View in: PubMed
    Score: 0.004
  30. Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer. Cancer. 2011 Apr 15; 117(8):1661-9.
    View in: PubMed
    Score: 0.004
  31. Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller. Int J Gynecol Cancer. 2010 Apr; 20(3):353-7.
    View in: PubMed
    Score: 0.003
  32. Pelvic fractures after radiotherapy for cervical cancer: implications for survivors. Cancer. 2010 Feb 01; 116(3):625-30.
    View in: PubMed
    Score: 0.003
  33. Phase 2 trial of mifepristone (RU-486) in advanced or recurrent endometrioid adenocarcinoma or low-grade endometrial stromal sarcoma. Cancer. 2009 May 01; 115(9):1867-74.
    View in: PubMed
    Score: 0.003
  34. A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer. Gynecol Oncol. 2009 May; 113(2):210-5.
    View in: PubMed
    Score: 0.003
  35. Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancer. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):1175-80.
    View in: PubMed
    Score: 0.003
  36. Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less. J Clin Oncol. 2007 Nov 01; 25(31):4946-51.
    View in: PubMed
    Score: 0.003
  37. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1081-7.
    View in: PubMed
    Score: 0.003
  38. Spectrum of imaging findings in the abdomen after radiotherapy. AJR Am J Roentgenol. 2006 Nov; 187(5):1204-11.
    View in: PubMed
    Score: 0.003
  39. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol. 2005 Dec 20; 23(36):9329-37.
    View in: PubMed
    Score: 0.003
  40. Hepatic adenoma. AJR Am J Roentgenol. 2004 Jun; 182(6):1520.
    View in: PubMed
    Score: 0.002
  41. The role of 18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors. J Nucl Med. 2004 Jan; 45(1):17-21.
    View in: PubMed
    Score: 0.002
  42. Diagnosis, staging, and surveillance of cervical carcinoma. AJR Am J Roentgenol. 2003 Jun; 180(6):1621-31.
    View in: PubMed
    Score: 0.002
  43. Utility of lymphangiography in the prediction of lymph node metastases in patients with cervical cancer. Int J Gynecol Cancer. 2002 Nov-Dec; 12(6):755-9.
    View in: PubMed
    Score: 0.002
  44. Brachial plexus: demonstration at US. Radiology. 1998 Aug; 208(2):402-6.
    View in: PubMed
    Score: 0.002
  45. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res. 1997 Sep; 3(9):1565-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.